Sumitomo Chemical India (SUMICHEM) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
5 Sep, 2025Executive summary
Achieved 18% YoY revenue growth in Q3FY25, driven by strong domestic and export volumes despite adverse weather and weak farmer sentiment.
Export revenues surged 38% YoY, with Latin America and Europe as key growth markets.
Unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2024 were approved by the Board on 27 January 2025.
The business is seasonal, with performance influenced by monsoon and climatic conditions.
Launched the second season of the 'Every Day Farmer Day' campaign, enhancing farmer engagement and brand trust.
Financial highlights
Q3FY25 consolidated revenue: ₹6,419.19 million (+18% YoY); 9MFY25 consolidated revenue: ₹24,691.03 million (+14% YoY).
Q3FY25 consolidated PAT: ₹874.30 million (+60% YoY); 9MFY25 consolidated PAT: ₹4,066.58 million (+56% YoY).
Q3FY25 EBITDA: ₹106.1 Cr (+61% YoY); 9MFY25 EBITDA: ₹512.5 Cr (+53% YoY).
Q3FY25 gross margin: 42.1% (up 239 bps YoY); EBITDA margin: 16.5% (up 439 bps YoY); PAT margin: 13.6% (up 352 bps YoY).
Basic and diluted EPS (standalone) for Q3FY25 was ₹1.69, up from ₹1.10 in Q3 FY24; for nine months, EPS was ₹8.08, up from ₹5.22 year-over-year.
Outlook and guidance
Targeting steady growth in FY25-26, contingent on a normal monsoon, with a focus on innovative product launches and operational efficiency.
Monitoring Rabi season progress, with higher sowing acreage expected to impact Q4FY25 results.
The company’s performance is expected to remain seasonal, with future results dependent on monsoon and climatic conditions.
Latest events from Sumitomo Chemical India
- 9MFY26 revenue rose 5% with margin gains, but Q3 saw profit drop from one-time Labour Code charge.SUMICHEM
Q3 25/2630 Jan 2026 - Record H1 FY25 profit and margin growth driven by new products, exports, and strong demand outlook.SUMICHEM
Q2 24/2518 Jan 2026 - Double-digit growth, record margins, and strong outlook, amid regulatory and climate risks.SUMICHEM
Q4 24/257 Jan 2026 - H1 FY26 delivered 9% revenue growth, robust cash flow, and new launches despite Q2 headwinds.SUMICHEM
Q2 25/2628 Oct 2025 - Record Q1FY26 revenue and profit growth, with strong margins and ongoing regulatory risks.SUMICHEM
Q1 25/265 Sep 2025 - Q1FY25 saw strong revenue and profit growth, improved margins, and ongoing legal and seasonal risks.SUMICHEM
Q1 24/255 Sep 2025